Xenon Pharmaceuticals Inc. · NASDAQ:XENE
Kelly Thomas Patrick bought 15,000 Xenon Pharmaceuticals Inc. shares (Form 4)
Traded Sep 30, 2026 · Filed Oct 1, 2026
On Sep 30, 2026, Kelly Thomas Patrick (Chief Financial Officer) bought 15,000 Xenon Pharmaceuticals Inc. shares at US$37.32 for US$560K, leaving 15,000 shares. Filed Oct 1, 2026 (Form 4).
- Bought
- 15,000 shares
- Price
- US$37.32
- Value
- US$560K
- Holding after
- 15,000 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | Common Shares | Buy | 15,000 | US$37.32 | 15,000 | Direct |
Source
Related
- Xenon Pharmaceuticals Inc.
- Kelly Thomas Patrick
- Xenon Pharmaceuticals Inc. shareholders
- Form 4 · Kelly Thomas Patrick · Oct 16, 2026
- Form 4 · Mortimer Ian · Oct 1, 2026
- Form 4 · Svoronos Dawn · Sep 3, 2026
- Form 4 · Kenney Christopher John · Aug 31, 2026
- Form 4 · Gannon Steven · Aug 13, 2026
- Schedule 13G/A · Wellington Management Group LLP · Aug 13, 2026